Robert Rosenthal, PhD, was appointed to the board of directors at InVivo Therapeutics on Nov. 8.
Three things to know:
1. InVivo is a clinical-stage biomaterials and biotechnology company focusing on the treatment of spinal cord injuries.
2. Dr. Rosenthal serves as chairman of the board of Taconic Biosciences and director at Safeguard Scientifics and Galvanic Applied Sciences, among other leadership positions.
3. He has more than 25 years of experience in leadership positions and plans to advance InVivo's "clinical pathway to ultimately address an … unmet need for spinal cord injury patients."